Yuri Blaauw
University Medical Center Groningen
QRS complexAtrium (architecture)Internal medicineCardiologyIntensive care medicineSinus rhythmCardiac resynchronization therapyCatheter ablationCardioversionFibrillationHeart failureAblationAtrial fibrillationPulmonary veinPersistent atrial fibrillationIn patientAnesthesiaRefractory periodMedicineEjection fraction
84Publications
24H-index
2,081Citations
Publications 83
Newest
#1Federico T Magni (UMCG: University Medical Center Groningen)
#2Meelad I H Al-Jazairi (UMCG: University Medical Center Groningen)H-Index: 4
Last. Yuri Blaauw (UMCG: University Medical Center Groningen)H-Index: 24
view all 0 authors...
AIMS This study evaluates the efficacy and safety of first-line single-stage hybrid ablation of (long-standing) persistent atrial fibrillation (AF), over a follow-up period of 2 years, and provides additional information on arrhythmia recurrences and electrophysiological findings at repeat ablation. METHODS AND RESULTS This is a prospective cohort study that included 49 patients (65% persistent AF; 35% long-standing persistent AF) who underwent hybrid ablation as first-line ablation treatment (n...
1 CitationsSource
#1Bart A. Mulder (UMCG: University Medical Center Groningen)H-Index: 10
#2Michiel Rienstra (UMCG: University Medical Center Groningen)H-Index: 54
Last. Yuri Blaauw (UMCG: University Medical Center Groningen)H-Index: 24
view all 4 authors...
Atrial fibrillation is increasingly encountered in patients with heart failure. Both diseases have seen tremendous rises in incidence in recent years. In general, the treatment of atrial fibrillation is focused on relieving patients from atrial fibrillation-related symptoms and risk reduction for thromboembolism and the occurrence or worsening of heart failure. Symptomatic relief may be accomplished by either (non-)pharmacological rate or rhythm control in combination with optimal therapy of und...
Source
#1A. H. Maass (UMCG: University Medical Center Groningen)H-Index: 1
#2M Klingenberg (UMCG: University Medical Center Groningen)
Last. Michiel Rienstra (UMCG: University Medical Center Groningen)H-Index: 54
view all 6 authors...
Source
#1Meelad I H Al-Jazairi (UMCG: University Medical Center Groningen)H-Index: 4
#2B O Nguyen (UMCG: University Medical Center Groningen)H-Index: 2
Last. Race InvestigatorsH-Index: 7
view all 16 authors...
Aims Maintaining sinus rhythm in patients with persistent atrial fibrillation (AF) is challenging. We explored the efficacy of class I and III antiarrhythmic drugs (AADs) in patients with persistent AF and mild to moderate heart failure (HF). Methods and results In the RACE 3 trial, patients with early persistent symptomatic AF and short history of mild to moderate HF with preserved or reduced left ventricular ejection fraction (LVEF) were randomized to targeted or conventional therapy. Both gro...
1 CitationsSource
#1Bart A. Mulder (UMCG: University Medical Center Groningen)H-Index: 10
#2Justin G.L.M. Luermans (UM: Maastricht University)H-Index: 15
Last. Yuri Blaauw (UMCG: University Medical Center Groningen)H-Index: 24
view all 4 authors...
Treatment of symptomatic atrial fibrillation has seen important changes in the past decades. Advancements have especially been made in the field of non-pharmacological treatment of this disease. Patients in whom a rhythm control strategy is chosen the place of catheter ablation has become more frontline therapy in the past years. The procedure itself has also seen changes in technologies that can be used, either using point-by-point radiofrequency or one of the single-shot techniques. One of the...
1 CitationsSource
#1H. F. Groenveld (UG: University of Groningen)
#2J. E. Coster (UG: University of Groningen)H-Index: 1
Last. Alexander H. Maass (UG: University of Groningen)H-Index: 23
view all 6 authors...
Implantable cardioverter defibrillators are implanted on a large scale in patients with heart failure (HF) for the prevention of sudden cardiac death. There are different scenarios in which defibrillator therapy is no longer desired or indicated, and this is occurring increasingly in elderly patients. Usually device therapy is continued until the device has reached battery depletion. At that time, the decision needs to be made to either replace it or to downgrade to a pacing-only device. This de...
Source
#1H. F. Groenveld (UG: University of Groningen)
#2Bart A. Mulder (UG: University of Groningen)H-Index: 10
Last. Yuri Blaauw (UG: University of Groningen)H-Index: 24
view all 3 authors...
Source
#1Alexander H. MaassH-Index: 1
Last. Yuri BlaauwH-Index: 24
view all 5 authors...
Left ventricular electrical delay can differentiate between ventricular and supraventricular tachycardia in cardiac resynchronization devices Alexander H. Maass, MD, PhD, Hessel F. Groenveld, MD, PhD, Bart A. Mulder, MD, PhD, Michiel Rienstra, MD, PhD, Yuri Blaauw, MD, PhD From the University of Groningen, University Medical Center Groningen, Heart Center, Department of Cardiology, Groningen, The NetherlandsAddress for correspondence: Alexander H. Maass, MD, PhD, University of Groningen, Univers...
Source
#1Daniel Mol (UvA: University of Amsterdam)H-Index: 3
#2Saskia HoutermanH-Index: 3
Last. Joris R. de Groot (UvA: University of Amsterdam)H-Index: 35
view all 18 authors...
Aims Pulmonary vein isolation (PVI) has become a cornerstone of the invasive treatment of atrial fibrillation. Severe complications are reported in 1-3% of patients. This study aims to compare complications and follow-up outcome of PVI in patients with atrial fibrillation. Methods and results The data were extracted from the Netherlands Heart Registration. Procedural and follow-up outcomes in patients treated with conventional radiofrequency (C-RF), multielectrode phased RF (Ph-RF), or cryoballo...
Source
#1Kevin J. Makati (USF: University of South Florida)H-Index: 4
#1Kevin J. Makati (USF: University of South Florida)H-Index: 4
Last. Jonathan S. Steinberg (UR: University of Rochester)H-Index: 65
view all 20 authors...
The absence of strategies to consistently and effectively address nonparoxysmal atrial fibrillation by nonpharmacological interventions has represented a long-standing treatment gap. A combined epicardial/endocardial ablation strategy, the hybrid Convergent procedure, was developed in response to this clinical need. A subxiphoid incision is used to access the pericardial space facilitating an epicardial ablation directed at isolation of the posterior wall of the left atrium. This is followed by ...
2 CitationsSource